Epstein Secrets

any "said the shots' effectiveness and a good safety record so far — with only temporary, flu-like side effects — mean they meet requirements set by the U.S. Food and Drug Administration for emergency use before the final-stage testing is complete," while the European Medicines Agency "has signaled it also is open to faster `conditi

On NBC Nightly News <https://playvideo.bulletinintelligence.com/d2ad675465494372ad1731e4a850eaa8? pubid=fbi> (11/30, 6:35 p.m. ET, story 2, 6.21M), Lester Holt reported that Moderna President Stephen Hoge in an interview "told me he expects approval very soon." Hoge: "We're quite optimistic actually that th

ny "said the shots' effectiveness and a good safety record so far - with only temporary, flu-like side effects - mean they meet requirements set by the U.S. Food and Drug Administration for emergency use before the final- stage testing is complete," while the European Medicines Agency "has signaled it also is open to faster 'conditi

ger for this pandemic." Bancel added, "We think it can really prevent severe disease." On NBC Nightly NewsVI (11/30, 6:35 p.m. ET, story 2, 6.21M), Lester Holt reported that Moderna President Stephen Hoge in an interview "told me he expects approval very soon." Hoge: "We're quite optimistic actually that t

ny "said the shots' effectiveness and a good safety record so far - with only temporary, flu-like side effects - mean they meet requirements set by the U.S. Food and Drug Administration for emergency use before the final- stage testing is complete," while the European Medicines Agency "has signaled it also is open to faster `conditi

nger for this pandemic." Bancel added, "We think it can really prevent severe disease." On NBC Nightly NewsVi (11/30, 6:35 p.m. Et story 2, 6.21M), Lester Holt reported that Moderna President Stephen Hoge in an interview "told me he expects approval very soon." Hoge: "We're quite optimistic actually that t